Ruthenium(II) Paracymene complexes of phenolic acids: Synthesis, chemical characterization, in-silico biomolecular interaction and cytotoxicity studies
- 22 September 2025
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 274, 113080
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Anti-tumor role and molecular mechanism of vanillic acidDiscover Oncology, 2025
- Experimental and Theoretical Study on the Biomolecular Interaction of Novel Acenaphtho Quinoxaline and Dipyridophenazine AnaloguesChemistrySelect, 2018
- Investigating Protein–Peptide Interactions Using the Schrödinger Computational Suite2017
- Cyclometalated Palladium(II) N‐Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth SuppressionAngewandte Chemie International Edition, 2016
- Antagonizing STAT3 Dimerization with a Rhodium(III) ComplexAngewandte Chemie, 2014
- The Potent Oxidant Anticancer Activity of Organoiridium CatalystsAngewandte Chemie, 2014
- Ruthenium-based chemotherapeutics: are they ready for prime time?Cancer Chemotherapy and Pharmacology, 2010
- KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor PatientsChemistry & Biodiversity, 2008
- Synthesis and pharmacological activities of some mononuclear Ru(II) complexesBioorganic & Medicinal Chemistry, 2005
- Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritisInternational Journal of Immunopharmacology, 1995